<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1384</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2005</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>19</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY OF KETOCONAZOLE FOR REDUCING THE RISK OF OVARIAN HYPERSTIMULATION SYNDROME</title>
	<subject_fa>Gynecology &amp; Obstetrics</subject_fa>
	<subject>Gynecology &amp; Obstetrics</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>

&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt text-align: justify&quot;&gt;&lt;b&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Calibri&quot;&gt;ABSTRACT&lt;o:p /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt text-align: justify&quot;&gt;&lt;font face=&quot;Calibri&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;b&gt;Background: &lt;/b&gt;In order to
evaluate the role ofketoconazole in the prevention of ovarian hyperstimulation
syndrome (OHSS) in women with polycystic ovary syndrome (PCOS) undergoing
ovarian stimulation with gonadotropins, a prospective, randomized, double-blind,
placebo controlled study was done on one-hundred and nine PCOS women that had
been refeiTed to be treated by gonadotropins.&lt;o:p /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt text-align: justify&quot;&gt;&lt;font face=&quot;Calibri&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;b&gt;Methods:&lt;/b&gt; Alll09 women were
assigned for random allocation. Group A (50 patients) received two ampoules
ofhMG beginning on day 2 or 3 of the cycle and ketoconazole (50 mg/every 48
hours) starting on the first day ofhMG treatment. Group B (51 patients)
received the same protocol ofhMG combined with one tablet of placebo every 48
hours. Main outcome measures were follicular development, E2levels, and
pregnancy rate.&lt;o:p /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt text-align: justify&quot;&gt;&lt;font face=&quot;Calibri&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;b&gt;Results:&lt;/b&gt; The total number
ofhMG ampoules and duration oftreatment to attain ovarian stimulation was
higher in group A (p&lt;O.OOO 1 ). Serum E2level and number of patients with
dominant follicles on day 9 of the cycle were higher in group B (p&lt;O.OOO 1
). There was no significant difference between semm E2level and total number of
follicles at the time ofhCG administration in the two groups. The cancellation
rate and OHSS rate were similar in the two groups.&lt;o:p /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin: 0in 0in 10pt text-align: justify&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Calibri&quot;&gt;&lt;b&gt;Conclusion:&lt;/b&gt; Ketoconazole
has no effect in prevention of OHSS in PCOS patients undergoing ovarian
stimulation. It may however reduce the rate of folliculogenesis and
steroidogenesis.&lt;o:p /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;3&quot;&gt; &lt;/font&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Polycystic ovary syndrome. ovarian hyperstimulation syndrome, ketoconazole.</keyword>
	<start_page>153</start_page>
	<end_page>158</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-307&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>MOHAMMAD EBRAHIM </first_name>
	<middle_name></middle_name>
	<last_name>PARSANEZHAD</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>parsame@sums.ac. ir</email>
	<code>20031947532846003036</code>
	<orcid>20031947532846003036</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>MAHNAZ </first_name>
	<middle_name></middle_name>
	<last_name>PAKNIAT</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003037</code>
	<orcid>20031947532846003037</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>SAEED </first_name>
	<middle_name></middle_name>
	<last_name>ALBORZI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003038</code>
	<orcid>20031947532846003038</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>ERNST HEINRICH</first_name>
	<middle_name></middle_name>
	<last_name> SCHMIDT</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003039</code>
	<orcid>20031947532846003039</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Obstetrics and Gynecology, Evang Diakrmie Teaching Hospital of the Gottingen University, Bremen, Germany.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
